Pure Global

FlexTest GC Blood Glucose/Cholesterol Dual Function Monitoring System - Taiwan Registration 7250ac4cf38b2b629cdf3fb5a8e82c84

Access comprehensive regulatory information for FlexTest GC Blood Glucose/Cholesterol Dual Function Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7250ac4cf38b2b629cdf3fb5a8e82c84 and manufactured by BIOPTIK TECHNOLOGY, INC.. The authorized representative in Taiwan is BIOPTIK TECHNOLOGY, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
7250ac4cf38b2b629cdf3fb5a8e82c84
Registration Details
Taiwan FDA Registration: 7250ac4cf38b2b629cdf3fb5a8e82c84
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

FlexTest GC Blood Glucose/Cholesterol Dual Function Monitoring System
TW: ๆ˜“็ซ‹ๆธฌ GC ่ก€็ณ–/่†ฝๅ›บ้†‡้›™ๅŠŸ่ƒฝ็›ฃๆธฌ็ณป็ตฑ
Risk Class 2

Registration Details

7250ac4cf38b2b629cdf3fb5a8e82c84

Company Information

Taiwan, Province of China

Product Details

This product is only suitable for in vitro diagnosis, and the blood glucose and cholesterol content are quantified by measuring fresh fingertip microvascular whole blood. This product is intended for single use only, but is not intended for testing of newborns.

A Clinical chemistry and clinical toxicology

A.1345 Glucose Test System

QMS/QSD;; ๅœ‹็”ข

Dates and Status

Jan 20, 2021

Jan 20, 2026